FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 107 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q2 2022. The put-call ratio across all filers is 6.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $460,000 | +191.1% | 23,036 | +0.3% | 0.00% | – |
| Q2 2022 | $158,000 | -26.2% | 22,956 | -0.2% | 0.00% | – |
| Q1 2022 | $214,000 | -34.6% | 23,004 | +0.1% | 0.00% | – |
| Q4 2021 | $327,000 | -38.8% | 22,979 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $534,000 | -21.8% | 23,047 | -16.0% | 0.00% | 0.0% |
| Q2 2021 | $683,000 | +3.8% | 27,445 | +16.8% | 0.00% | 0.0% |
| Q1 2021 | $658,000 | +8.4% | 23,500 | +35.1% | 0.00% | 0.0% |
| Q4 2020 | $607,000 | -16.6% | 17,400 | +19.2% | 0.00% | 0.0% |
| Q3 2020 | $728,000 | – | 14,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |